VolitionRx Company
VolitionRx develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.
Technology:
diagnostics
Industry:
Clinical Development, Early Drug Development, Preclinical Development
Headquarters:
Singapore, Central Region, Singapore
Founded Date:
2010-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
1
Total Funding:
44327746
Estimated Revenue:
Less than $1M
Last Funding Date:
2023-02-17
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership